| Title: | The MC1R r allele does not increase melanoma risk in MITF E318K carriers |
| Journal: | British Journal of Dermatology |
| Published: | 5 Mar 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/36879448/ |
| DOI: | https://doi.org/10.1093/bjd/ljad041 |
| URL: | https://academic.oup.com/bjd/advance-article-pdf/doi/10.1093/bjd/ljad041/49425059/ljad041.pdf |
Publication 11172
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Population-wide screening for melanoma is not cost-effective, but genetic characterization could facilitate risk stratification and targeted screening. Common Melanocortin-1 receptor (MC1R) red hair colour (RHC) variants and Microphthalmia-associated transcription factor (MITF) E318K separately confer moderate melanoma susceptibility, but their interactive effects are relatively unexplored.</p>
OBJECTIVES: To evaluate whether MC1R genotypes differentially affect melanoma risk in MITF E318K+ vs. E318K- individuals.</p>
MATERIALS AND METHODS: Melanoma status (affected or unaffected) and genotype data (MC1R and MITF E318K) were collated from research cohorts (five Australian and two European). In addition, RHC genotypes from E318K+ individuals with and without melanoma were extracted from databases (The Cancer Genome Atlas and Medical Genome Research Bank, respectively). χ2 and logistic regression were used to evaluate RHC allele and genotype frequencies within E318K+/- cohorts depending on melanoma status. Replication analysis was conducted on 200 000 general-population exomes (UK Biobank).</p>
RESULTS: The cohort comprised 1165 MITF E318K- and 322 E318K+ individuals. In E318K- cases MC1R R and r alleles increased melanoma risk relative to wild type (wt), P < 0.001 for both. Similarly, each MC1R RHC genotype (R/R, R/r, R/wt, r/r and r/wt) increased melanoma risk relative to wt/wt (P < 0.001 for all). In E318K+ cases, R alleles increased melanoma risk relative to the wt allele [odds ratio (OR) 2.04 (95% confidence interval 1.67-2.49); P = 0.01], while the r allele risk was comparable with the wt allele [OR 0.78 (0.54-1.14) vs. 1.00, respectively]. E318K+ cases with the r/r genotype had a lower but not significant melanoma risk relative to wt/wt [OR 0.52 (0.20-1.38)]. Within the E318K+ cohort, R genotypes (R/R, R/r and R/wt) conferred a significantly higher risk compared with non-R genotypes (r/r, r/wt and wt/wt) (P < 0.001). UK Biobank data supported our findings that r did not increase melanoma risk in E318K+ individuals.</p>
CONCLUSIONS: RHC alleles/genotypes modify melanoma risk differently in MITF E318K- and E318K+ individuals. Specifically, although all RHC alleles increase risk relative to wt in E318K- individuals, only MC1R R increases melanoma risk in E318K+ individuals. Importantly, in the E318K+ cohort the MC1R r allele risk is comparable with wt. These findings could inform counselling and management for MITF E318K+ individuals.</p>
27 Authors
- Courtney K Wallingford
- Anastassia Demeshko
- Asha Krishnankutty Krishnakripa
- Darren J Smit
- David L Duffy
- Brigid Betz-Stablein
- Annette Pflugfelder
- Kasturee Jagirdar
- Elizabeth Holland
- Graham J Mann
- Clare A Primiero
- Tatiane Yanes
- Josep Malvehy
- Cèlia Badenas
- Cristina Carrera
- Paula Aguilera
- Catherine M Olsen
- Sarah V Ward
- Nikolas K Haass
- Richard A Sturm
- Susana Puig
- David C Whiteman
- Matthew H Law
- Anne E Cust
- Miriam Potrony
- H Peter Soyer
- Aideen M McInerney-Leo
Enabling scientific discoveries that improve human health